CDK8 inhibitor KY-065 rescues skeletal abnormalities in achondroplasia model mice
Featured image source: https://ars.els-cdn.com/content/image/1-s2.0-S0925443924006203-ga1_lrg.jpg A new study highlights KY-065, a CDK8 inhibitor, as a potential breakthrough treatment for achondroplasia (ACH). ACH, the most common form of genetic dwarfism, is caused…
